TF and non-small cell lung carcinoma: During the past decade, network approach based on TF–miRNA FFLs has been demonstrated as a promising tool to dissect the etiology of many tumors [13], such as glioblastoma [14], ovarian cancer [15], non-small-cell lung cancer (NSCLC) [16] and T-cell acute lymphoblastic leukemia [17].